# Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-efficacy-of-the-new-oral-small-molecule-glp-1-receptor-agonists/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paschalis Karakasis,Dimitrios Patoulias,Konstantinos Pamporis,Panagiotis Stachteas,Konstantinos I. Bougioukas,Aleksandra Klisić,Nikolaos Fragakis,Manfredi Rizzo |
| Citations | 62 |
| DOI | 10.1016/j.metabol.2023.155710 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4387675741 |
| PMID | 37852529 |
| Type | review |
| Year | 2023 |

## Paper authors

- [Paschalis Karakasis](https://scholariq.org/researchers/paschalis-karakasis/)
- [Dimitrios Patoulias](https://scholariq.org/researchers/dimitrios-patoulias/)

## Paper journal

- [Metabolism](https://scholariq.org/journals/metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.